Complete Donald Trump Stock Impact Guide

Go back to Complete Donald Trump Stock Impact Guide

AstraZeneca (AZN) Tops Q3 EPS by 6c

November 10, 2016 8:27 AM UTC

AstraZeneca (NYSE: AZN) reported Q3 EPS of $0.80, $0.06 better than the analyst estimate of $0.74. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.95 billion.

Pascal Soriot, Chief Executive Officer, commenting on the results said:

The performance in the third quarter was in line with our expectations,... More

Valeant Pharma (VRX) Receives Subpoena from California Department of Insurance

November 9, 2016 4:44 PM UTC

Valeant Pharma (NYSE: VRX) disclosed the following in its Form 10-Q on Wednesday:

Investigation by the California Department of Insurance

On or about September 16, 2016,... More